Linda S. Grais founded SGX Pharmaceuticals, Inc. and Structural Genomix, Inc. Dr. Grais is Director at Research Bridge Partners. Dr. Grais is also on the board of 8 other companies.

In her past career she was Managing Member & Partner at InterWest Partners LLC, Attorney at Wilson Sonsini Goodrich & Rosati PC, President, Chief Executive Officer & Director at Ocera Therapeutics, Inc., Executive Vice President of SGX Pharmaceuticals, Inc., Executive Vice President for Structural Genomix, Inc. and Assistant Clinical Professor at The University of California, San Francisco.

Dr. Grais received an undergraduate degree from Yale University, a graduate degree from Stanford Law School and a doctorate from Yale School of Medicine.